Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 1998

View Archived Issues

Predictors of vascular access site complications during angioplasty with eptifibatide

Zopiclone improves sleep in rheumatoid arthritis patients

Cardiotoxicity of dexverapamil makes it unsuitable for reversing resistance in breast cancer

New estrogenic/antioxidant agents developed by AHP

Japan Energy prepares HIV protease-inhibitory dipeptides

NMDA subtype-selective blockers prepared and evaluated at Roche

Investigation at Sumitomo leads to new psychotropic agents

PDE inhibitors from Kyorin useful as bronchodilators

Alizyme granted exclusive worldwide license to BTG drug delivery technology

Avax to begin pivotal trial with M-Vax in melanoma patients

Schizophrenia collaboration between Neurogen and Schering-Plough ends successfully

Label expansion for CEPRATE SC approved

Clinical trials to begin shortly with KT-7515/CEP-1347

Antifungal therapeutics, diagnostics collaboration initiated by Phytera and Lilly

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...